Nishinomiya, Japan

Noriko Akimaru

This inventor holds 1 USPTO granted patent. Top assignee: Toshikazu Nakamura and Sumitomo Pharmaceuticals Co., Ltd.. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Noriko Akimaru. Retrieved from https://idiyas.com/inventor/noriko-akimaru

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Noriko Akimaru: Innovator in Biotechnology

Introduction

Noriko Akimaru is a prominent inventor based in Nishinomiya, Japan. She has made significant contributions to the field of biotechnology, particularly through her innovative work on peg-modified hepatocyte growth factor (HGF). With a focus on enhancing therapeutic applications, her research has the potential to impact various medical treatments.

Latest Patents

Noriko Akimaru holds 1 patent for her invention related to peg-modified HGF. This patent represents a crucial advancement in the development of biopharmaceuticals, showcasing her expertise and dedication to improving healthcare solutions.

Career Highlights

Throughout her career, Noriko has worked with esteemed organizations, including Toshikazu Nakamura and Sumitomo Pharmaceuticals Co., Ltd. Her role in these companies has allowed her to collaborate with leading experts in the field, further enhancing her contributions to biotechnology.

Collaborations

Noriko has collaborated with notable colleagues such as Mitsuo Namiki and Naoto Kusunose. These partnerships have fostered a dynamic research environment, enabling the exchange of ideas and the development of innovative solutions in the biotechnology sector.

Conclusion

Noriko Akimaru's work exemplifies the spirit of innovation in biotechnology. Her contributions, particularly in peg-modified HGF, highlight her commitment to advancing medical science and improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…